Frahm, Niklas http://orcid.org/0000-0002-4655-774X
Hecker, Michael http://orcid.org/0000-0001-7015-3094
Zettl, Uwe Klaus
Article History
Received: 26 July 2018
Accepted: 13 February 2019
First Online: 6 March 2019
Competing Interests
: M.H. received speaking fees and travel funds from Bayer HealthCare, Biogen, Novartis and Teva. U.K.Z. received research support as well as speaking fees and travel funds from Almirall, Bayer HealthCare, Biogen, Merck Serono, Novartis, Sanofi and Teva. N.F. declares no financial competing interests. M.H., U.K.Z. and N.F. declare no non-financial competing interests.